AU8737701A - Purification, characterization and use of protective antigenic structures against trypanosomes and related parasites - Google Patents

Purification, characterization and use of protective antigenic structures against trypanosomes and related parasites

Info

Publication number
AU8737701A
AU8737701A AU87377/01A AU8737701A AU8737701A AU 8737701 A AU8737701 A AU 8737701A AU 87377/01 A AU87377/01 A AU 87377/01A AU 8737701 A AU8737701 A AU 8737701A AU 8737701 A AU8737701 A AU 8737701A
Authority
AU
Australia
Prior art keywords
characterization
purification
structures against
antigenic structures
protective antigenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU87377/01A
Inventor
Derek Nolan
Etienne Pays
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite Libre de Bruxelles ULB
Original Assignee
SAMUEL J BLACK
TERRY PEARSON
Universite Libre de Bruxelles ULB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SAMUEL J BLACK, TERRY PEARSON, Universite Libre de Bruxelles ULB filed Critical SAMUEL J BLACK
Publication of AU8737701A publication Critical patent/AU8737701A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/005—Trypanosoma antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L69/00—Network arrangements, protocols or services independent of the application payload and not provided for in the other groups of this subclass
    • H04L69/16—Implementation or adaptation of Internet protocol [IP], of transmission control protocol [TCP] or of user datagram protocol [UDP]
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L69/00—Network arrangements, protocols or services independent of the application payload and not provided for in the other groups of this subclass
    • H04L69/30—Definitions, standards or architectural aspects of layered protocol stacks
    • H04L69/32—Architecture of open systems interconnection [OSI] 7-layer type protocol stacks, e.g. the interfaces between the data link level and the physical level
    • H04L69/322—Intralayer communication protocols among peer entities or protocol data unit [PDU] definitions
    • H04L69/329—Intralayer communication protocols among peer entities or protocol data unit [PDU] definitions in the application layer [OSI layer 7]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
AU87377/01A 2000-09-06 2001-09-06 Purification, characterization and use of protective antigenic structures against trypanosomes and related parasites Withdrawn AU8737701A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US23183900P 2000-09-06 2000-09-06
US60231839 2000-09-06
USNOTGIVEN 2000-11-08
PCT/BE2001/000146 WO2002019960A2 (en) 2000-09-06 2001-09-06 Purification, characterization and use of protective antigenic structures against trypanosomes and related parasites

Publications (1)

Publication Number Publication Date
AU8737701A true AU8737701A (en) 2002-03-22

Family

ID=22870818

Family Applications (1)

Application Number Title Priority Date Filing Date
AU87377/01A Withdrawn AU8737701A (en) 2000-09-06 2001-09-06 Purification, characterization and use of protective antigenic structures against trypanosomes and related parasites

Country Status (2)

Country Link
AU (1) AU8737701A (en)
WO (1) WO2002019960A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010000849A2 (en) * 2008-07-04 2010-01-07 Institut De Recherche Pour Le Developpement (I.R.D.) A method for the screening of conserved secreted proteins
FR2952382B1 (en) 2009-11-10 2011-11-25 Univ Victor Segalen Bordeaux 2 VACCINES AND DIAGNOSES AGAINST AFRICAN ANIMAL TRYPANOSOMOSES
FR2952649B1 (en) * 2009-11-13 2012-05-04 Univ Victor Segalen Bordeaux 2 THERAPEUTIC AND DIAGNOSTIC APPLICATIONS AGAINST AFRICAN ANIMAL TRYPANOSOMOSES

Also Published As

Publication number Publication date
WO2002019960A2 (en) 2002-03-14

Similar Documents

Publication Publication Date Title
AU2002336760A1 (en) Mutable vaccines
HK1078266A1 (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same
AU2001291859A1 (en) Use of copolycarbonates
AU2002314466A1 (en) Withasol and methods of use
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2002219135A1 (en) Substituted 2-anilino-benzimidazoles and the use thereof as NHE-inhibitors
AU2001277526A1 (en) Substituted benzo-nitro-heterocycles and use thereof as herbicides
AU2001240637A1 (en) Novel imidazotriazinones and the use thereof
AU2001288972A1 (en) Antipsychotic sulfonamide-heterocycles, and methods of use thereof
AU2002310237A1 (en) Sponge-derived terpenoids and methods of use
AU2001252627A1 (en) Polybenzasol fiber and use of the same
AU8737701A (en) Purification, characterization and use of protective antigenic structures against trypanosomes and related parasites
AU4432001A (en) Trityl-type compounds and their use
AU2000231564A1 (en) Phosphororganic compounds and the use thereof
AU2001276258A1 (en) Ceramic component and the use thereof
AU2001233588A1 (en) New toralactone and its derivation and the use of decreasing blood-fat and losing weight
AU2002320079A1 (en) Vaccines, immunotherapeutics and methods of using the same
AU2001247286A1 (en) Integrated optical transceiver and related methods
AU2001266512A1 (en) Optical device and fabrication thereof
AU6286101A (en) New use
AU2001242024A1 (en) Hair loss prevention
AU2001287897A1 (en) Manipulation of spermatozoa
AU2000234766A1 (en) Cloned human lysophospholipase
AU2002224528A1 (en) New use
AU2001265768A1 (en) Ceramic component and use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase